X hits on this document

471 views

0 shares

0 downloads

0 comments

126 / 147

directly or indirectly, to officers, employees, or agents of the State of New Mexico, for Levaquin,

UltramlUltracet, and other drugs.

569.

By

virtue

of

the

above-described

acts,

among

others,

Defendant

Janssen

knowingly caused to be presented false or fraudulent claims for payment or approval, and

possibly continues to cause to be submitted false or fraudulent claims for payment or approval,

directly or indirectly, to officers, employees, or agents of the State of New Mexico, for Risperdal

and other drugs.

570.

As a result of the claims for reimbursement defendants caused to be submitted to

New Mexico Medicaid, which were certified compliant with federal and state Medicaid law and

regulation as a condition of payment by co-conspirator pharmacies, New Mexico regularly made

payments to pharmacies for Defendant Manufacturers' illegally switched drugs.

571.

The amounts of the false or fraudulent claims to the State of New Mexico were

material.

572.

Plaintiff State of New Mexico, being unaware of the falsity of the claims and/or

statements caused to be made by the Defendant Manufacturers, and in reliance on the accuracy

thereof paid and may continue to pay for the Defendant Manufacturers' improperly switched

prescriptions.

All

unlawful

conduct

described

above

may

have

continued

after

Lisitza's

termination with Omnicare.

COUNT XXXII Conspiracy to Snbmit False Claims in Violation of the New Mexico Medicaid False Claims Act N.M. Stat. §27-14-4D (Against All Defendants)

  • 573.

    Plaintiffs reallege and incorporate by reference Paragraphs 1-261 set forth above.

  • 574.

    By effectuating the PAL letter solicitation-for-kickback scheme detailed herein,

122

Document info
Document views471
Page views471
Page last viewedSat Dec 03 12:01:22 UTC 2016
Pages147
Paragraphs7751
Words41508

Comments